Compounds > phosphatidylcholines
Page last updated: 2024-09-05

phosphatidylcholines and Osteoporosis, Postmenopausal

phosphatidylcholines has been researched along with Osteoporosis, Postmenopausal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fu, M; Tian, Y; Wang, J; Zhan, Q; Zhang, L; Zhang, T1
Dalle Carbonare, L; Garbin, U; Manfro, S; Pasini, A; Stranieri, C; Valenti, MT; Zanatta, M; Zucal, C1

Other Studies

2 other study(ies) available for phosphatidylcholines and Osteoporosis, Postmenopausal

ArticleYear
Comparative study of DHA-enriched phosphatidylcholine and EPA-enriched phosphatidylcholine on ameliorating high bone turnover
    Food & function, 2020, Nov-18, Volume: 11, Issue:11

    Topics: Animals; beta Catenin; Bone and Bones; Bone Density; Bone Remodeling; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Mice; Mice, Inbred C57BL; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; Phosphatidylcholines; Signal Transduction; Wnt Proteins; Wnt Signaling Pathway

2020
Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPARĪ³2 expression in MSCs-like of osteoporotic patients.
    PloS one, 2011, Volume: 6, Issue:6

    Topics: Adipogenesis; Case-Control Studies; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Densitometry; Female; Gene Expression Regulation; Humans; Mesenchymal Stem Cells; Middle Aged; Osteogenesis; Osteoporosis, Postmenopausal; Phenotype; Phosphatidylcholines; PPAR gamma; Serum

2011